First line treatment with carboplatin-paclitaxel-bevacizumab in ovarian cancer: retrospective review of a single institute experience-MedSci.cn

First line treatment with carboplatin-paclitaxel-bevacizumab in ovarian cancer: retrospective review of a single institute experience

Bologna, A; Garcia-Arias, A; Baldi, L; Berselli, A; Pagano, M; Zanelli, F; Bisagni, G; Gervasi, E; Stridi, G; Candida, B; Romagnani, A; Gnoni, R

ANNALS OF ONCOLOGY, 2017; 28 ( ):

科室
- - 订阅+
  - 更多科室
工具
服务